Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP175458568 | Newsroom Ready: Health Canada approves 1st pill to treat postpartum depression
Placeline/People
State Province
Ontario
Country
Canada
Health Canada approves 1st pill to treat postpartum depression
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days. Canadian Press reporter Nicole Ireland shares what experts have told her about the drug. (Dec. 9, 2025)
Actions
Add to collection
Add to cart
Information
Source name:
The Canadian Press
Unique identifier:
CP175458710
Legacy Identifier:
e_Postpartum-Depression-Drug20251209T1655
Type:
Video
Duration:
3m19s
Dimensions:
1920px × 1080px 191.01 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
12/9/2025 4:55:00 PM
Display aspect ratio:
16:9
Tags
Depression
drug
health
Health Canada
life
medication
postpartum
postpartum depression
treatment